Procter & Gamble (PG)
NYSEConsumer StaplesHousehold & Personal ProductsSnapshot 2026-09-14
$146.66+0.36%
Close 2026-09-15 · 1-day change
NYSEConsumer StaplesHousehold & Personal ProductsSnapshot 2026-09-14
Research Workspace
Put PG beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Consumer Staples is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Maintain EPS growth between 1% and 6% in fiscal 2026: EPS growth ~4.7% vs 1% to 6% target.
View ThesisRevenue is growing steadily — about 3% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityManagement screens strong on capital allocation, earnings delivery, margins, the balance sheet.
View ManagementExpectations look high — the market is pricing in about 25% growth a year, above the roughly 3% analysts expect, leaving little room for error.
View ValuationRelatively steady — typically moves about 1% a day.
View RiskProcter & Gamble's growth depends on maintaining EPS growth between 1% and 6%. Recent earnings show EPS growth around 4.7%, which is within the target range. The company beat earnings expectations in the last quarter. It trades at 21× P/E, above the 16× peer median. The market expects more growth than the company forecasts, indicating full expectations. If Procter & Gamble cuts guidance, it could negatively impact the stock. Peer multiples imply a price about 24% below where it trades. This read is provisional; the thesis is on watch.
Trailing returns as of 2026-09-15. PG is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 25 analysts currently covering PG (as of Sep 2026).
Based on 3 Wall Street analysts offering 12-month price targets for PG in the last 4 months.
Continue this research
Compare PG with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Free account required to save the handoff. No credit card.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| PG Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 13 valuation methods, at three horizons. As of 2026-09-14. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Consumer Staples (broad) — fair value, gap to price, and forward P/E.
Compare the value case
Put PG next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Higher supplier costs could impact earnings growth.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-09-15. EPS is implied from price ÷ P/E. Not investment advice.
Current $146.66
The last 12 months of price, then the range of analyst 12-month targets from today’s $146.66.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Threatens: Sustain diluted net earnings per share growth of 1-5% in fiscal 2027
Margins under pressure could hinder earnings growth.
Threatens: Sustain diluted net earnings per share growth of 1-5% in fiscal 2027
EPS growth concerns may hinder long-term earnings objectives.
Threatens: Sustain diluted net earnings per share growth of 1-5% in fiscal 2027
EPS headwind impacts earnings growth objective.
Threatens: Deliver organic sales growth of 1-3% in fiscal 2027
Challenges to growth strategy may hinder organic sales growth.
Threatens: Deliver organic sales growth of 1-3% in fiscal 2027
Costly outlook may hinder organic sales growth.
Threatens: Maintain adjusted free cash flow productivity of 85-90%
Concerns over dividend growth impact cash flow productivity.
Acquisition aligns with growth strategy and expands product offerings.